Bill

Bill > HB738


VA HB738

VA HB738
Virginia Consumer Protection Act; prohibited practices, kratom products.


summary

Introduced
01/13/2026
In Committee
01/13/2026
Crossed Over
Passed
Dead

Introduced Session

2026 Regular Regular Session

Bill Summary

Virginia Consumer Protection Act; prohibited practices; kratom products. Prohibits the selling or offering for sale of (i) any kratom product containing any synthesized material, semi-synthetic alkaloid, or synthetic kratom-like compound; (ii) any kratom product containing 7-hydroxymitragynine in an alkaloid fraction exceeding two percent of total alkaloids in the container or providing more than one milligram of 7-hydroxymitragynine per serving; (iii) any kratom product adulterated with any dangerous, poisonous, or otherwise deleterious non-kratom ingredient, including any substance listed as a controlled substance under state or federal law; (iv) any kratom product that is combustible or intended for vaporization or injection; (v) any kratom product that is manufactured, packaged, or marketed in a manner attractive to children; or (vi) any kratom extract product containing residual solvent levels exceeding applicable statutory or pharmacopeial limits.

AI Summary

This bill amends the Virginia Consumer Protection Act to prohibit the sale or offering for sale of certain kratom products, which is a substance derived from the Mitragyna speciosa plant. Specifically, it bans kratom products that contain any synthetic materials or compounds, have a high concentration of 7-hydroxymitragynine (a key alkaloid in kratom) exceeding two percent of total alkaloids or one milligram per serving, are mixed with dangerous non-kratom ingredients including controlled substances, are intended for combustion, vaporization, or injection, are packaged or marketed in a way that appeals to children, or have residual solvent levels above legal limits. The bill also adds a requirement that all kratom products must be labeled with ingredient information and a warning stating that the product may be harmful, has not been evaluated by the FDA, and is not intended to diagnose, treat, cure, or prevent any disease.

Committee Categories

Business and Industry, Justice

Sponsors (21)

Last Action

Left in Committee General Laws (on 02/18/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...